Cardiff Oncology: Q4 Earnings Insights

 

Cardiff Oncology CRDF reported its Q4 earnings results on Thursday, February 24, 2022 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Cardiff Oncology missed estimated earnings by 35.29%, reporting an EPS of $-0.23 versus an estimate of $-0.17.

Revenue was up $14.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.93% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRDF Logo
CRDFCardiff Oncology Inc
$3.10-1.90%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
Not Available
Growth
Not Available
Quality
Not Available
Value
2.89
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...